AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE was reported 155 times

These side effects are most commonly reported by patients taking AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE:

# Side effect Count
0 SKIN CANCER 32
1 BASAL CELL CARCINOMA 14
2 NEOPLASM MALIGNANT 13
3 MALIGNANT MELANOMA 12
4 RASH 11
5 BURNS THIRD DEGREE 9
6 RECALLED PRODUCT ADMINISTERED 7
7 SUNBURN 7
8 DRUG INEFFECTIVE 6
9 PRURITUS 6
10 SQUAMOUS CELL CARCINOMA 6
11 APPLICATION SITE BURN 5
12 PRODUCT LOT NUMBER ISSUE 5
13 URTICARIA 5
14 APPLICATION SITE RASH 4
15 BLISTER 4
16 BREAST CANCER 4
17 HYPERSENSITIVITY 4
18 PRODUCT EXPIRATION DATE ISSUE 4
19 RASH PRURITIC 4
20 ADVERSE EVENT 3
21 APPLICATION SITE ERYTHEMA 3
22 APPLICATION SITE PAIN 3
23 APPLICATION SITE SWELLING 3
24 COUGH 3
25 PRODUCT CONTAMINATION CHEMICAL 3
26 SKIN DISCOLOURATION 3
27 SKIN EXFOLIATION 3
28 ACCIDENTAL EXPOSURE TO PRODUCT 2
29 ACUTE MYELOID LEUKAEMIA 2
30 ANGIOEDEMA 2
31 APPLICATION SITE REACTION 2
32 CHEMICAL BURN 2
33 DERMATITIS ATOPIC 2
34 DIZZINESS 2
35 ERYTHEMA 2
36 EXPIRED PRODUCT ADMINISTERED 2
37 HAEMATOLOGICAL MALIGNANCY 2
38 LEUKAEMIA 2
39 PHOTOSENSITIVITY REACTION 2
40 POST INFLAMMATORY PIGMENTATION CHANGE 2
41 PRODUCT QUALITY ISSUE 2
42 RASH ERYTHEMATOUS 2
43 ABDOMINAL DISTENSION 1
44 ABNORMAL WEIGHT GAIN 1
45 ANXIETY 1
46 APPENDIX CANCER 1
47 APPLICATION SITE DRYNESS 1
48 APPLICATION SITE EXFOLIATION 1
49 APPLICATION SITE HYPERSENSITIVITY 1
50 APPLICATION SITE IRRITATION 1
51 APPLICATION SITE PUSTULES 1
52 APPLICATION SITE SCAR 1
53 APPLICATION SITE VESICLES 1
54 ARTHROPOD BITE 1
55 BLADDER CANCER 1
56 BLADDER CANCER STAGE III 1
57 BLOOD BLISTER 1
58 BONE PAIN 1
59 BURNING SENSATION 1
60 CHEST DISCOMFORT 1
61 CONFUSIONAL STATE 1
62 DEATH 1
63 DERMATITIS 1
64 DERMATITIS ALLERGIC 1
65 DERMATITIS CONTACT 1
66 DRUG HYPERSENSITIVITY 1
67 DRY SKIN 1
68 DYSPNOEA 1
69 ECZEMA 1
70 EXPOSURE TO TOXIC AGENT 1
71 EXPOSURE VIA INHALATION 1
72 EYE DISORDER 1
73 EYE SWELLING 1
74 FURUNCLE 1
75 GAIT DISTURBANCE 1
76 HAEMORRHAGE 1
77 HEADACHE 1
78 HYPOAESTHESIA ORAL 1
79 ILL-DEFINED DISORDER 1
80 INCORRECT PRODUCT ADMINISTRATION DURATION 1
81 INFLUENZA LIKE ILLNESS 1
82 LACRIMATION INCREASED 1
83 LIP BLISTER 1
84 MELANOCYTIC NAEVUS 1
85 MILIARIA 1
86 MOLLUSCUM CONTAGIOSUM 1
87 MONOCLONAL GAMMOPATHY 1
88 NASAL CONGESTION 1
89 NON-HODGKIN^S LYMPHOMA 1
90 OROPHARYNGEAL PAIN 1
91 OTITIS MEDIA ACUTE 1
92 PAPULE 1
93 PARAESTHESIA ORAL 1
94 PLASMA CELL MYELOMA 1
95 PRECANCEROUS CONDITION 1
96 PRECANCEROUS SKIN LESION 1
97 PRODUCT ADMINISTRATION ERROR 1
98 PRODUCT CONTAINER ISSUE 1
99 PRODUCT CONTAMINATION 1
100 PRODUCT FORMULATION ISSUE 1
101 PRODUCT LABEL ISSUE 1
102 PRODUCT PACKAGE ASSOCIATED INJURY 1
103 PRODUCT PACKAGING ISSUE 1
104 PRODUCT USE IN UNAPPROVED INDICATION 1
105 PRODUCTIVE COUGH 1
106 PROSTATE CANCER 1
107 RASH MACULAR 1
108 RASH PAPULAR 1
109 RASH VESICULAR 1
110 RECALLED PRODUCT 1
111 RED BLOOD CELL COUNT DECREASED 1
112 RENAL CANCER 1
113 SECOND DEGREE CHEMICAL BURN OF SKIN 1
114 SKIN BURNING SENSATION 1
115 SKIN FISSURES 1
116 SKIN IRRITATION 1
117 SWELLING FACE 1
118 THERMAL BURN 1
119 THIRD DEGREE CHEMICAL BURN OF SKIN 1
120 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1
121 URINE ODOUR ABNORMAL 1
122 VASCULITIS 1
123 WRONG ROUTE 1
124 XEROSIS 1